Gilead Sciences: Supreme Court Case and New Innovations Drive Buy Rating | Markets Insider
Michael Yee, an analyst from Jefferies, maintained the Buy rating on Gilead Sciences (GILD – Research Report). The associated price target remai...
Wall Street
2025-01-15
Comments
Share your comments